Free Trial

Genpact Limited (NYSE:G) Holdings Lowered by Fiduciary Management Inc. WI

Genpact logo with Business Services background

Fiduciary Management Inc. WI lessened its holdings in Genpact Limited (NYSE:G - Free Report) by 3.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,145,480 shares of the business services provider's stock after selling 349,450 shares during the period. Genpact comprises about 3.7% of Fiduciary Management Inc. WI's portfolio, making the stock its 4th largest holding. Fiduciary Management Inc. WI owned 5.19% of Genpact worth $392,798,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. HighTower Advisors LLC purchased a new stake in shares of Genpact during the third quarter worth about $232,000. Stifel Financial Corp acquired a new position in shares of Genpact during the third quarter valued at approximately $1,197,000. Orion Portfolio Solutions LLC purchased a new position in shares of Genpact in the third quarter valued at approximately $211,000. MML Investors Services LLC lifted its position in shares of Genpact by 31.4% in the third quarter. MML Investors Services LLC now owns 12,058 shares of the business services provider's stock valued at $473,000 after acquiring an additional 2,879 shares in the last quarter. Finally, M&T Bank Corp acquired a new stake in shares of Genpact in the third quarter worth approximately $206,000. Institutional investors and hedge funds own 96.03% of the company's stock.

Genpact Stock Up 0.5 %

Shares of NYSE:G traded up $0.26 during trading on Thursday, hitting $47.81. 335,864 shares of the company were exchanged, compared to its average volume of 1,467,503. The firm's 50 day moving average price is $50.04 and its 200-day moving average price is $46.20. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The stock has a market capitalization of $8.40 billion, a P/E ratio of 16.83, a PEG ratio of 1.84 and a beta of 1.06.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, research analysts predict that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.42%. This is a boost from Genpact's previous quarterly dividend of $0.15. The ex-dividend date of this dividend was Tuesday, March 11th. Genpact's dividend payout ratio is presently 23.94%.

Analyst Ratings Changes

Several research analysts recently commented on the company. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and increased their price objective for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Needham & Company LLC raised their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Mizuho upped their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and raised their target price for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $50.38.

Read Our Latest Stock Report on G

Insider Buying and Selling

In other news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. This trade represents a 4.20 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 2.80% of the company's stock.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines